Bill Detail

H.R. 4752

Congress: 119

Title

Reducing Hereditary Cancer Act

Summary

Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Sponsor

Rep. Debbie Wasserman Schultz [D-FL-25]

Status

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Status as of Aug 5, 8:00 PM · synced 8d ago

Introduced

2025-07-23

Data source mode: congress-gov

Bill Engagement

Lobbyists on the case

3 orgs · 35 lobbyists · 3 filings mention H.R. 4752 (Reducing Hereditary Cancer Act) in LDA disclosures.
Top orgs filing
Lobbyists on this bill
+ 33 more in the full intelligence view

Prepared intelligence brief

Put this record in the joined picture.

Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.

Get your intelligence briefAlready a customer? Sign inGet free intelligence alerts →